Entera Book Value per Share vs Current Ratio Analysis

ENTX Stock

USD 2.52 0.46 15.44%

Entera Bio financial indicator trend analysis is much more than just examining Entera Bio latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Entera Bio is a good investment. Please check the relationship between Entera Bio Book Value Per Share and its Current Ratio accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Book Value Per Share vs Current Ratio

Book Value per Share vs Current Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Entera Bio Book Value per Share account and Current Ratio. At this time, the significance of the direction appears to have strong relationship.

The correlation between Entera Bio's Book Value per Share and Current Ratio is 0.61. Overlapping area represents the amount of variation of Book Value per Share that can explain the historical movement of Current Ratio in the same time period over historical financial statements of Entera Bio, assuming nothing else is changed. The correlation between historical values of Entera Bio's Book Value per Share and Current Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value per Share of Entera Bio are associated (or correlated) with its Current Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Current Ratio has no effect on the direction of Book Value per Share i.e., Entera Bio's Book Value per Share and Current Ratio go up and down completely randomly.

Correlation Coefficient

0.61

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Current Ratio

A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.

Most indicators from Entera Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Entera Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.At this time, Entera Bio's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 51.15 in 2024, despite the fact that Tax Provision is likely to grow to (16.1 K).

	2023	2024 (projected)
Interest Income	854.5K	696.3K
Reconciled Depreciation	59K	84.1K

Interest Income Reconciled Depreciation

Entera Bio fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Long Term Debt	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Short Long Term Debt	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment
Total Assets		-0.75	0.68	0.2	0.82	0.82	0.81	0.61	-0.96	-0.72	0.05	0.99	-0.24	-0.82	1.0	0.54	-0.67	0.28	0.77	-0.64	0.59	0.72	1.0	-0.6	-0.52	0.61
Short Long Term Debt Total	-0.75		-0.38	0.31	-0.86	-0.45	-0.86	-0.51	0.9	0.82	-0.35	-0.73	0.25	0.65	-0.77	-0.56	0.75	-0.17	-0.83	0.8	-0.68	-0.91	-0.75	0.63	0.66	-0.63
Other Current Liab	0.68	-0.38		0.24	0.43	0.6	0.42	0.75	-0.6	-0.23	-0.41	0.68	0.16	-0.4	0.67	0.02	-0.3	-0.09	0.29	-0.27	0.39	0.36	0.68	-0.26	-0.24	0.44
Total Current Liabilities	0.2	0.31	0.24		0.05	0.35	0.03	0.11	0.01	0.06	-0.09	0.19	0.24	-0.44	0.18	-0.09	-0.14	-0.18	-0.01	0.03	0.14	-0.22	0.2	-0.24	0.08	0.23
Total Stockholder Equity	0.82	-0.86	0.43	0.05		0.54	1.0	0.6	-0.88	-0.88	0.2	0.8	-0.31	-0.74	0.83	0.66	-0.96	0.25	0.93	-0.96	0.74	0.72	0.82	-0.92	-0.72	0.69
Other Liab	0.82	-0.45	0.6	0.35	0.54		0.52	0.41	-0.71	-0.32	0.12	0.8	0.18	-0.58	0.81	0.25	-0.4	0.0	0.46	-0.34	0.5	0.51	0.81	-0.36	-0.12	0.63
Net Tangible Assets	0.81	-0.86	0.42	0.03	1.0	0.52		0.62	-0.88	-0.9	0.18	0.79	-0.34	-0.74	0.82	0.68	-0.96	0.27	0.94	-0.97	0.75	0.72	0.82	-0.92	-0.75	0.67
Property Plant And Equipment Net	0.61	-0.51	0.75	0.11	0.6	0.41	0.62		-0.62	-0.56	-0.41	0.64	-0.09	-0.47	0.62	0.42	-0.54	0.13	0.6	-0.53	0.7	0.52	0.61	-0.5	-0.62	0.48
Net Debt	-0.96	0.9	-0.6	0.01	-0.88	-0.71	-0.88	-0.62		0.83	-0.19	-0.96	0.29	0.78	-0.96	-0.64	0.73	-0.31	-0.86	0.74	-0.69	-0.85	-0.96	0.64	0.63	-0.66
Retained Earnings	-0.72	0.82	-0.23	0.06	-0.88	-0.32	-0.9	-0.56	0.83		-0.21	-0.74	0.56	0.75	-0.74	-0.86	0.83	-0.5	-0.94	0.85	-0.72	-0.71	-0.73	0.77	0.9	-0.55
Accounts Payable	0.05	-0.35	-0.41	-0.09	0.2	0.12	0.18	-0.41	-0.19	-0.21		0.06	0.12	-0.21	0.05	0.21	-0.22	-0.09	0.25	-0.24	0.27	0.38	0.05	-0.17	0.04	0.43
Cash	0.99	-0.73	0.68	0.19	0.8	0.8	0.79	0.64	-0.96	-0.74	0.06		-0.29	-0.78	0.99	0.63	-0.64	0.38	0.79	-0.61	0.62	0.71	0.99	-0.57	-0.56	0.62
Non Current Assets Total	-0.24	0.25	0.16	0.24	-0.31	0.18	-0.34	-0.09	0.29	0.56	0.12	-0.29		0.21	-0.27	-0.73	0.27	-0.92	-0.51	0.31	0.11	-0.2	-0.27	0.25	0.43	0.33
Long Term Debt	-0.82	0.65	-0.4	-0.44	-0.74	-0.58	-0.74	-0.47	0.78	0.75	-0.21	-0.78	0.21		-0.81	-0.49	0.68	-0.14	-0.72	0.61	-0.62	-0.66	-0.82	0.65	0.58	-0.56
Cash And Short Term Investments	1.0	-0.77	0.67	0.18	0.83	0.81	0.82	0.62	-0.96	-0.74	0.05	0.99	-0.27	-0.81		0.57	-0.67	0.32	0.79	-0.65	0.59	0.74	1.0	-0.61	-0.54	0.6
Common Stock Shares Outstanding	0.54	-0.56	0.02	-0.09	0.66	0.25	0.68	0.42	-0.64	-0.86	0.21	0.63	-0.73	-0.49	0.57		-0.61	0.81	0.86	-0.63	0.54	0.54	0.56	-0.57	-0.69	0.33
Non Current Liabilities Total	-0.67	0.75	-0.3	-0.14	-0.96	-0.4	-0.96	-0.54	0.73	0.83	-0.22	-0.64	0.27	0.68	-0.67	-0.61		-0.18	-0.89	0.99	-0.74	-0.58	-0.67	0.99	0.71	-0.67
Other Current Assets	0.28	-0.17	-0.09	-0.18	0.25	0.0	0.27	0.13	-0.31	-0.5	-0.09	0.38	-0.92	-0.14	0.32	0.81	-0.18		0.49	-0.21	-0.03	0.17	0.31	-0.16	-0.37	-0.21
Other Stockholder Equity	0.77	-0.83	0.29	-0.01	0.93	0.46	0.94	0.6	-0.86	-0.94	0.25	0.79	-0.51	-0.72	0.79	0.86	-0.89	0.49		-0.9	0.74	0.78	0.78	-0.83	-0.74	0.58
Total Liab	-0.64	0.8	-0.27	0.03	-0.96	-0.34	-0.97	-0.53	0.74	0.85	-0.24	-0.61	0.31	0.61	-0.65	-0.63	0.99	-0.21	-0.9		-0.72	-0.63	-0.64	0.95	0.73	-0.64
Property Plant And Equipment Gross	0.59	-0.68	0.39	0.14	0.74	0.5	0.75	0.7	-0.69	-0.72	0.27	0.62	0.11	-0.62	0.59	0.54	-0.74	-0.03	0.74	-0.72		0.65	0.58	-0.69	-0.7	0.89
Short Long Term Debt	0.72	-0.91	0.36	-0.22	0.72	0.51	0.72	0.52	-0.85	-0.71	0.38	0.71	-0.2	-0.66	0.74	0.54	-0.58	0.17	0.78	-0.63	0.65		0.72	-0.47	-0.45	0.53
Total Current Assets	1.0	-0.75	0.68	0.2	0.82	0.81	0.82	0.61	-0.96	-0.73	0.05	0.99	-0.27	-0.82	1.0	0.56	-0.67	0.31	0.78	-0.64	0.58	0.72		-0.61	-0.53	0.59
Short Term Debt	-0.6	0.63	-0.26	-0.24	-0.92	-0.36	-0.92	-0.5	0.64	0.77	-0.17	-0.57	0.25	0.65	-0.61	-0.57	0.99	-0.16	-0.83	0.95	-0.69	-0.47	-0.61		0.67	-0.63
Intangible Assets	-0.52	0.66	-0.24	0.08	-0.72	-0.12	-0.75	-0.62	0.63	0.9	0.04	-0.56	0.43	0.58	-0.54	-0.69	0.71	-0.37	-0.74	0.73	-0.7	-0.45	-0.53	0.67		-0.51
Property Plant Equipment	0.61	-0.63	0.44	0.23	0.69	0.63	0.67	0.48	-0.66	-0.55	0.43	0.62	0.33	-0.56	0.6	0.33	-0.67	-0.21	0.58	-0.64	0.89	0.53	0.59	-0.63	-0.51

Click cells to compare fundamentals

Entera Bio Account Relationship Matchups

Entera Bio fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	16.7M	10.3M	26.0M	13.1M	11.8M	13.9M
Other Current Liab	3.8M	(189K)	2.8M	(134K)	874K	1.3M
Total Current Liabilities	4.6M	3.3M	3.2M	1.3M	1.1M	1.0M
Total Stockholder Equity	11.9M	6.7M	22.6M	11.8M	10.4M	10.9M
Net Tangible Assets	11.3M	6.1M	22.6M	11.8M	13.5M	14.2M
Property Plant And Equipment Net	462K	192K	395K	139K	488K	305.4K
Net Debt	(14.9M)	(8.2M)	(24.6M)	(12.2M)	(10.6M)	(11.2M)
Retained Earnings	(62.9M)	(72.9M)	(82.4M)	(95.5M)	(104.4M)	(99.2M)
Accounts Payable	334K	1.8M	166K	1.3M	83K	78.9K
Cash	15.2M	8.6M	24.9M	12.3M	11.0M	11.8M
Non Current Assets Total	1.1M	1.2M	658K	278K	508K	631.1K
Cash And Short Term Investments	15.2M	8.6M	24.9M	12.3M	11.0M	12.3M
Common Stock Shares Outstanding	12.1M	18.4M	26.1M	28.8M	29.0M	19.3M
Liabilities And Stockholders Equity	16.7M	10.3M	26.0M	13.1M	11.8M	13.9M
Non Current Liabilities Total	192K	324K	261K	32K	288K	273.6K
Other Current Assets	97K	93K	254K	294K	238K	188.5K
Other Stockholder Equity	63.4M	70.6M	105.0M	107.2M	114.7M	63.3M
Total Liab	4.8M	3.6M	3.4M	1.4M	1.4M	1.3M
Property Plant And Equipment Gross	462K	548K	395K	229K	488K	359.9K
Total Current Assets	15.6M	9.1M	25.3M	12.8M	11.3M	13.0M
Accumulated Other Comprehensive Income	13.1M	11.4M	9.0M	41K	36.9K	35.1K
Property Plant Equipment	462K	548K	395K	229K	263.4K	337.8K
Non Currrent Assets Other	(1.1M)	356K	46K	96K	6K	5.7K
Net Invested Capital	11.9M	6.7M	22.6M	11.8M	10.4M	7.2M
Net Working Capital	11.0M	5.8M	22.2M	11.5M	10.2M	12.9M
Current Deferred Revenue	267K	1.4M	15K	43K	38.7K	36.8K

Pair Trading with Entera Bio

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Entera Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Entera Bio will appreciate offsetting losses from the drop in the long position's value.

Moving against Entera Stock

0.83	BIIB	Biogen Inc Financial Report 23rd of April 2024	Pair Corr
0.75	VRTX	Vertex Pharmaceuticals Financial Report 6th of May 2024	Pair Corr
0.75	AMGN	Amgen Inc Financial Report 25th of April 2024	Pair Corr
0.64	JNJ	Johnson Johnson Earnings Call Today	Pair Corr
0.57	ABVC	ABVC Biopharma	Pair Corr

The ability to find closely correlated positions to Entera Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Entera Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Entera Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Entera Bio to buy it.

The correlation of Entera Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Entera Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Entera Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Entera Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Entera Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Entera Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Entera Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Entera Bio Stock:

How To Invest In Entera

Details

Is Entera Stock a good investment?

Details

What is Entera Bio's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Entera Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Entera Stock analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.

	Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk

Is Entera Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Entera Bio. If investors know Entera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Entera Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.31)

Quarterly Revenue Growth

(0.92)

Return On Assets

(0.45)

Return On Equity

(0.80)

The market value of Entera Bio is measured differently than its book value, which is the value of Entera that is recorded on the company's balance sheet. Investors also form their own opinion of Entera Bio's value that differs from its market value or its book value, called intrinsic value, which is Entera Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Entera Bio's market value can be influenced by many factors that don't directly affect Entera Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Entera Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Entera Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Entera Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Entera Book Value per Share vs Current Ratio Analysis

Book Value Per Share vs Current Ratio

Book Value per Share vs Current Ratio Correlation Analysis

Correlation Coefficient

Book Value Per Share

Current Ratio

Entera Bio fundamental ratios Correlations

Entera Bio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Entera Bio fundamental ratios Accounts

Pair Trading with Entera Bio

Moving against Entera Stock

Complementary Tools for Entera Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Total Current Assets	+ 1.0	Cash And Short Term Investments
Cash	+ 0.99	Total Assets
Cash And Short Term Investments	+ 0.99	Cash

Total Liab	- 0.97	Net Tangible Assets
Total Current Assets	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt
Cash	- 0.96	Net Debt
Non Current Liabilities Total	- 0.96	Net Tangible Assets
Total Liab	- 0.96	Total Stockholder Equity